MELOXICAM TABLETS
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
Defense Logistics Agency award SPE2DP24F2049 was issued on May 28, 2026, to DMS Pharmaceutical Group Inc under delivery order SPE2DX15D9383. The contract was established for the procurement of Meloxicam Tablets, identified by NSN 6505015413243, as part of a commercial items order managed by the DLA Troop Support Medical Supply Chain FSB. Following the initial award, Modification P00001 was issued on May 28, 2026, resulting in a total cancellation of the contract at no cost or liability to either party. This modification cancelled CLIN 0001 and reduced the total contract amount from 16.00 dollars to 0.00 dollars because the material was no longer required due to a ship decommissioning scheduled for September 2026.
General Info
Place of Performance
Not specifiedSet-Aside
Documents
2AI Contract Breakdown
Uniform Contract FormatContract not broken down yet
CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Earlier notices in this NAICS code
Posted before this notice, open and closed
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
